TN2013000141A1 - Substituted n-(2-arylamino) aryl sulfonamide-containing combinations - Google Patents
Substituted n-(2-arylamino) aryl sulfonamide-containing combinationsInfo
- Publication number
- TN2013000141A1 TN2013000141A1 TNP2013000141A TN2013000141A TN2013000141A1 TN 2013000141 A1 TN2013000141 A1 TN 2013000141A1 TN P2013000141 A TNP2013000141 A TN P2013000141A TN 2013000141 A TN2013000141 A TN 2013000141A TN 2013000141 A1 TN2013000141 A1 TN 2013000141A1
- Authority
- TN
- Tunisia
- Prior art keywords
- component
- arylamino
- combinations
- aryl sulfonamide
- substituted
- Prior art date
Links
- 125000004421 aryl sulphonamide group Chemical group 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- GWEHVDNNLFDJLR-UHFFFAOYSA-N 1,3-diphenylurea Chemical class C=1C=CC=CC=1NC(=O)NC1=CC=CC=C1 GWEHVDNNLFDJLR-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000009434 installation Methods 0.000 abstract 1
- 238000007912 intraperitoneal administration Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to : * combinations of : component A : one or more omega-carboxyaryl-substituted diphenyl urea compounds of general formula (I), or a physiologically acceptable salt, solvate, hydrate or stereoisomer thereof; component B : one or more N-(2-arylamino) aryl sulfonamide compounds of general formula (II), or a physiologically acceptable salt, solvate, hydrate or stereoisomer thereof; and, optionally, component C : one or more further pharmaceutical agents; in which optionally some or all of the components are in the form of a pharmaceutical formulation which is ready for use to be administered simultaneously, concurrently, separately or sequentially. dependently of one another by the oral, intravenous, topical, local installations, intraperitoneal or nasal route; * use of such combinations for the preparation of a medicament for the treatment or prophylaxis of a cancer; and * a kit comprising such a combination.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2011/067041 WO2012041987A1 (en) | 2010-10-01 | 2011-09-29 | Substituted n-(2-arylamino)aryl sulfonamide-containing combinations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2013000141A1 true TN2013000141A1 (en) | 2014-06-25 |
Family
ID=54360806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2013000141A TN2013000141A1 (en) | 2011-09-29 | 2013-03-29 | Substituted n-(2-arylamino) aryl sulfonamide-containing combinations |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2013000141A1 (en) |
-
2013
- 2013-03-29 TN TNP2013000141A patent/TN2013000141A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013500580A1 (en) | Substituted n-(2-arylamino) aryl sulfonamide-containing combinations | |
| TN2012000493A1 (en) | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations | |
| CY1119490T1 (en) | PYRAZOLOPYROLIDINE PRODUCTS AND THEIR USE IN PATIENT TREATMENT | |
| EA201590371A1 (en) | 1,4-DESIGNED PYRIDAZIN ANALOGUES AND METHODS OF TREATMENT RELATED TO SMN DEFICIENCY CONDITIONS | |
| UA109698C2 (en) | AZAINDASOL OR DIAZAINDASOL DERIVATIVES AS A MEDICINE | |
| EA201201680A1 (en) | MORFOLINOPYRIMIDINES AND THEIR APPLICATION IN THERAPY | |
| EA202090860A1 (en) | THIADIAZOL ANALOGUES AND METHODS FOR TREATMENT OF CONDITIONS RELATED TO SMN DEFICIENCY | |
| EA201490864A1 (en) | DERIVATIVES (4-PHENYLIMIDAZOL-2-IL) ETYLAMINE AS SODIUM CHANNEL MODULATORS | |
| EA201490471A1 (en) | PYRIDAZINOUS COMPOUNDS AND THEIR APPLICATION AS DAAO INHIBITORS | |
| EA201591195A1 (en) | NEW QUINOLON DERIVATIVES | |
| EA201400358A1 (en) | SUBSTITUTED N- [1-CYANO-2- (PHENYL) ETHYL] -2-AZABICYCLO [2.2.1] HEPTAN-3-CARBOXAMIDE INHIBITORS KATEPSIN C | |
| EA201391018A1 (en) | PREPARATIONS OF IMMUNOSUPRESSANTS | |
| WO2012135615A3 (en) | Enopeptins, uses thereof, and methods of synthesis thereto | |
| EA201400064A1 (en) | OPHTHALMIC PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION THAT CONTAINS REGORAPHENIB | |
| EA201391524A1 (en) | GLYCOSIDE DERIVATIVES AND THEIR APPLICATION | |
| EA201490573A1 (en) | CONTAINING BENZOTHIAZOLONE | |
| IN2014KN01113A (en) | ||
| EA201390488A1 (en) | NEW GPR 119 AGONISTS | |
| TN2013000141A1 (en) | Substituted n-(2-arylamino) aryl sulfonamide-containing combinations | |
| UA111851C2 (en) | PIRIDASINONE COMPOUNDS AND THEIR USE AS DAAO INHIBITORS |